Back | Next |
home / stock / amrn / amrn message board
Subject | By | Source | When |
---|---|---|---|
Okay great, I understand your point, thank you. | Nukemtiltheyglow | investorshub | 07/14/2024 4:32:11 PM |
Rose...verify the efficacy of the product(Vaskepa) to reduce | ziploc_1 | investorshub | 07/14/2024 4:30:25 PM |
Not sure if this has been discussed, but | rosemountbomber | investorshub | 07/14/2024 1:01:18 PM |
Good Sunday morning. It's certainly been an interesting | CaptBeer | investorshub | 07/14/2024 12:32:54 PM |
Question is how much is VAZKEPA is in | Sammy 967 | investorshub | 07/13/2024 9:54:45 PM |
Capt, Thanks for response. I'll dig into the | Jasbg | investorshub | 07/13/2024 9:16:55 PM |
No question the opportunity is there. The | rosemountbomber | investorshub | 07/13/2024 7:24:46 PM |
C.B....Its been estimated that the total Chinese patient | ziploc_1 | investorshub | 07/13/2024 6:55:52 PM |
Now lets look at this startling statistic: YEARS | CaptBeer | investorshub | 07/13/2024 6:54:32 PM |
Good Saturday morning my friends. By now youve | CaptBeer | investorshub | 07/13/2024 6:20:24 PM |
Capt, another great post to put things in | DAR53 | investorshub | 07/13/2024 5:39:23 PM |
Jasbg, It depends on what your questions are. | CaptBeer | investorshub | 07/13/2024 5:37:29 PM |
Lizzy, Got it. | Number sleven | investorshub | 07/13/2024 4:55:59 PM |
sleven, should have said patent. Didn't finish my | lizzy241 | investorshub | 07/13/2024 4:46:50 PM |
Capt, From where does most people get their | Jasbg | investorshub | 07/13/2024 4:41:36 PM |
Good Saturday morning my friends. By now youve | CaptBeer | investorshub | 07/13/2024 4:32:02 PM |
Lizzy, What application? | Number sleven | investorshub | 07/13/2024 4:09:19 PM |
north, if Amarin had competent attorneys who conducted | lizzy241 | investorshub | 07/13/2024 3:53:54 PM |
I dont disagree with you North and obviously | rosemountbomber | investorshub | 07/13/2024 3:09:09 PM |
Ill have to disagree with much of what | north40000 | investorshub | 07/13/2024 2:01:15 PM |
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
Amarin Corporation plc Website:
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD) 1 -- -- Approval marks eighth national reimbursement of VAZKEPA®...
DUBLIN and BRIDGEWATER, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s senior management team to discuss its second quarter 2024 results followed ...
-- VASCEPA Approved by the National Medical Products Administration (NMPA) To Reduce the Risk of Cardiovascular Events as an Adjunct to Statin Therapy in Adult Patients with Elevated Triglyceride (TG) Levels (≥150 mg/dL) and Other High-Risk Characteristics as Studied in REDUCE-IT -- ...